Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials

Saved in:
Bibliographic Details
Other Authors: Gumbinger, Christoph (Other) , Reuter, Björn (Other) , Stock, Christian (Other) , Sauer, Tamara (Other) , Kern, Rolf (Other) , Ringleb, Peter A. (Other) , Hennerici, Michael G. (Other) , Hacke, Werner (Other)
Format: Article (Journal)
Language:English
Published: 2014
In: The BMJ
Year: 2014, Volume: 348
ISSN:1756-1833
DOI:10.1136/bmj.g3429
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1136/bmj.g3429
Get full text
Author Notes:Christoph Gumbinger; Björn Reuter; Christian Stock; Tamara Sauer ... Rolf Kern; Peter Ringleb; Michael G Hennerici; Werner Hacke

MARC

LEADER 00000caa a22000002c 4500
001 1480085839
003 DE-627
005 20220811100858.0
007 cr uuu---uuuuu
008 140725s2014 xx |||||o 00| ||eng c
024 7 |a 10.1136/bmj.g3429  |2 doi 
035 |a (DE-627)1480085839 
035 |a (DE-576)410085839 
035 |a (DE-599)BSZ410085839 
035 |a (OCoLC)1340643408 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice  |b retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials  |c Christoph Gumbinger; Björn Reuter; Christian Stock; Tamara Sauer ... Rolf Kern; Peter Ringleb; Michael G Hennerici; Werner Hacke 
264 1 |c 2014 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
700 1 |a Gumbinger, Christoph  |0 (DE-588)138155178  |0 (DE-627)696381117  |0 (DE-576)306183927  |4 oth 
700 1 |a Reuter, Björn  |d 1979-  |0 (DE-588)141344415  |0 (DE-627)626891361  |0 (DE-576)323197310  |4 oth 
700 1 |a Stock, Christian  |d 1978-  |0 (DE-588)123325218  |0 (DE-627)706256530  |0 (DE-576)29365624X  |4 oth 
700 1 |a Sauer, Tamara  |d 1983-  |0 (DE-588)1012484599  |0 (DE-627)704870282  |0 (DE-576)345340000  |4 oth 
700 1 |a Kern, Rolf  |d 1972-  |0 (DE-588)1025172248  |0 (DE-627)72138143X  |0 (DE-576)370036476  |4 oth 
700 1 |a Ringleb, Peter A.  |0 (DE-588)1032676175  |0 (DE-627)73863364X  |0 (DE-576)172917743  |4 oth 
700 1 |a Hennerici, Michael G.  |d 1948-  |0 (DE-588)11587545X  |0 (DE-627)077527704  |0 (DE-576)290126444  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
773 0 8 |i In  |t The BMJ  |d London : BMJ Publ. Group, 1988  |g 348(2014) Artikel-Nr. g3429, 12 S.  |h Online-Ressource  |w (DE-627)271349190  |w (DE-600)1479799-9  |w (DE-576)078590574  |x 1756-1833  |7 nnas  |a Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials 
773 1 8 |g volume:348  |g year:2014  |g extent:12  |a Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials 
856 4 0 |u http://dx.doi.org/10.1136/bmj.g3429  |q application/pdf  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20140725 
993 |a Article 
994 |a 2014 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 11  |y j 
998 |g 11587545X  |a Hennerici, Michael G.  |m 11587545X:Hennerici, Michael G.  |d 60000  |d 62700  |e 60000PH11587545X  |e 62700PH11587545X  |k 0/60000/  |k 1/60000/62700/  |p 10 
998 |g 1032676175  |a Ringleb, Peter A.  |m 1032676175:Ringleb, Peter A.  |d 910000  |d 911100  |e 910000PR1032676175  |e 911100PR1032676175  |k 0/910000/  |k 1/910000/911100/  |p 9 
998 |g 1025172248  |a Kern, Rolf  |m 1025172248:Kern, Rolf  |d 60000  |d 62700  |e 60000PK1025172248  |e 62700PK1025172248  |k 0/60000/  |k 1/60000/62700/  |p 8 
998 |g 1012484599  |a Sauer, Tamara  |m 1012484599:Sauer, Tamara  |d 60000  |d 62700  |e 60000PS1012484599  |e 62700PS1012484599  |k 0/60000/  |k 1/60000/62700/  |p 4 
998 |g 123325218  |a Stock, Christian  |m 123325218:Stock, Christian  |d 910000  |d 999701  |e 910000PS123325218  |e 999701PS123325218  |k 0/910000/  |k 1/910000/999701/  |p 3 
998 |g 141344415  |a Reuter, Björn  |m 141344415:Reuter, Björn  |d 60000  |d 62700  |e 60000PR141344415  |e 62700PR141344415  |k 0/60000/  |k 1/60000/62700/  |p 2 
998 |g 138155178  |a Gumbinger, Christoph  |m 138155178:Gumbinger, Christoph  |d 910000  |d 911100  |e 910000PG138155178  |e 911100PG138155178  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1480085839  |e 2808013922 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"BMJ","title":"The BMJ"}],"language":["eng"],"part":{"volume":"348","year":"2014","text":"348(2014) Artikel-Nr. g3429, 12 S.","extent":"12"},"pubHistory":["297.1988 -"],"recId":"271349190","origin":[{"dateIssuedDisp":"1988-","publisher":"BMJ Publ. Group","dateIssuedKey":"1988","publisherPlace":"London"}],"titleAlt":[{"title":"BMJ. British medical journal (Clinical research ed.)"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trialsThe BMJ","id":{"eki":["271349190"],"issn":["1756-1833"],"zdb":["1479799-9"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 02.10.20"]}],"physDesc":[{"extent":"12 S."}],"id":{"eki":["1480085839"],"doi":["10.1136/bmj.g3429"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"recId":"1480085839","person":[{"family":"Gumbinger","role":"oth","given":"Christoph","display":"Gumbinger, Christoph"},{"role":"oth","given":"Björn","display":"Reuter, Björn","family":"Reuter"},{"family":"Stock","role":"oth","given":"Christian","display":"Stock, Christian"},{"display":"Sauer, Tamara","role":"oth","given":"Tamara","family":"Sauer"},{"display":"Kern, Rolf","given":"Rolf","role":"oth","family":"Kern"},{"given":"Peter A.","role":"oth","display":"Ringleb, Peter A.","family":"Ringleb"},{"display":"Hennerici, Michael G.","role":"oth","given":"Michael G.","family":"Hennerici"},{"family":"Hacke","display":"Hacke, Werner","given":"Werner","role":"oth"}],"language":["eng"],"name":{"displayForm":["Christoph Gumbinger; Björn Reuter; Christian Stock; Tamara Sauer ... Rolf Kern; Peter Ringleb; Michael G Hennerici; Werner Hacke"]},"title":[{"title":"Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice","subtitle":"retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials","title_sort":"Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice"}]} 
SRT |a TIMETOTREA2014